ALHC Trading Analysis - 10/23/2026 03:17 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge headlines and context for ALHC (Alignment Healthcare) that may relate to the data-driven sections below:

• ALHC announced expanded Medicare Advantage plan offerings in multiple states for the 2026 enrollment season, a potential catalyst for membership growth.
• The company reported a narrower quarterly net loss vs. prior year in its most recent earnings, though margins remain under pressure from medical cost ratios.
• Analysts have flagged sector-wide reimbursement uncertainty heading into 2027 as a risk for managed-care names including ALHC.
• Insider and institutional ownership remains elevated (~77% per fundamentals), suggesting limited float but potential for sharp moves on flows.
• A mid-October 2026 price gap lower (10/09 close $7.56 from $8.75 prior) coincided with a broad healthcare selloff, not company-specific news.

Context: These items illustrate a fundamental story of modest improvement but regulatory overhang. The embedded data shows a stock well below prior highs and bearish options conviction, consistent with cautious sentiment despite stable daily closes near $8.40.

Fundamental Analysis

Based strictly on the embedded FUNDAMENTALS data for ALHC:

• Trailing P/E: 42.60; Trailing EPS: $0.20 — valuation is rich versus many healthcare peers, with no forward P/E (null) or PEG (null) to justify growth.
• Market Cap: $1.66B; Shares Outstanding: 207.44M; Institutional Percent: 77.01% — heavily institution-owned, low retail float.
• Dividend Yield: 0.00% (no dividend); Beta: 0.69 — less volatile than market broadly, but Historical Volatility: 102.81% signals stock-specific turbulence.
• 52-Week High: $25.12; 52-Week Low: $6.01 — current ~$8.40 sits near 11% above the low, far below the high.
• Missing data: revenue growth, profit margins, ROE, debt/equity, free cash flow, analyst target — all null, preventing margin-quality assessment.
• Fundamentals show modest profitability (EPS positive) but expensive multiple and absent growth metrics; this diverges from the technical picture of a beaten-down, range-bound stock with bearish options flow.

Current Market Position

Current price per indicators: $8.41 (2026-10-22 close $8.41, indicators current_price $8.40 formatted to $8.41). Minute bars show 2026-10-23 14:30 drop to $7.91 low then recovery to $8.00 at 14:50.

Recent daily action: 2026-10-22 close $8.41 after trading $8.35–$8.55. 30-day range high $13.33, low $6.01. Price is in lower-third of 30-day range.

Intraday momentum: Opening 2026-10-22 at $8.44, drifting to $8.36 by 09:30 next-day bars, then sharp volume spike (2.12M at 14:30) pushed low $7.91 before stabilization $7.97–$8.00.

Technical Analysis

SMA alignment: SMA 5 ($8.42) > SMA 20 ($8.23) > price ($8.41) > SMA 50 ($10.52) — bearish structure, price below 50-day. No bullish cross; 5 over 20 is minor near-term strength only.

RSI 56.50: neutral-to-slightly bullish momentum, not overbought. MACD negative (-0.56 vs signal -0.45, hist -0.11): bearish momentum persisting. Bollinger: price $8.41 between middle $8.23 and upper $8.80, no squeeze (band width $1.15). 30-day range: price $8.41 is 18.6% above low $6.01, 36.9% below high $13.33.

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-10-23 15:17) using Delta 40-60 filter:

Call Volume: $1,290.00 (5.2%) Put Volume: $23,735.00 (94.8%) Total: $25,025.00

Call contracts: 6 / Put contracts: 101. Sentiment: Bearish. Pure directional conviction strongly favors puts — 18.4x put dollar volume vs calls.

This suggests near-term downside expectations, contrasting with neutral RSI and minor SMA-5/SMA-20 strength. Divergence: technicals stable ~$8.40, but options signal institutional hedge/short bias.

Key Price Levels (observational only)